This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Serv. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yong-Chen Lu: Innovator in T Cell Receptor Research
Introduction
Yong-Chen Lu is a notable inventor based in Little Rock, Arkansas. He has made significant contributions to the field of immunology, particularly in the development of T cell receptors. His work is crucial for advancing cancer therapies and understanding immune responses.
Latest Patents
Yong-Chen Lu holds a patent titled "T Cell Receptors Recognizing HLA-CW8 Restricted Mutated KRAS." This patent represents a significant advancement in the ability to target specific cancer mutations, which can lead to more effective treatments for patients.
Career Highlights
Lu is affiliated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His research focuses on the intersection of immunology and cancer treatment, showcasing his commitment to improving patient outcomes through innovative therapies.
Collaborations
Yong-Chen Lu has collaborated with esteemed colleagues such as Eric Tran and Steven A. Rosenberg. These partnerships enhance the research efforts and contribute to the development of groundbreaking therapies in the field.
Conclusion
Yong-Chen Lu's work exemplifies the impact of innovative research in immunology. His contributions, particularly through his patent, are paving the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile